Dais (DLYT) 10-Q 28 Jun 23 2023 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2023	Jun. 28, 2023
Cover [Abstract]
Entity Registrant Name	DAIS CORPORATION
Entity Central Index Key	0001125699
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Mar. 31, 2023
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Entity Common Stock Shares Outstanding		20,149,365
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-53554
Entity Incorporation State Country Code	NY
Entity Tax Identification Number	14-1760865
Entity Interactive Data Current	Yes
Entity Address Address Line 1	11552 Prosperous Drive
Entity Address City Or Town	Odessa
Entity Address State Or Province	FL
Entity Address Postal Zip Code	33556
City Area Code	727
Local Phone Number	375-8484

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash	$ 37,149	$ 27,412
Accounts receivable, net	127,616	258,708
Inventory	336,492	294,472
Prepaid expenses	18,990	25,871
Reimbursements receivable	36,743	0
Total Current Assets	556,990	606,463
Property and equipment, net	31,493	32,400
OTHER ASSETS:
Deposits	4,780	4,780
Patents, net	148,045	150,048
Total Other Assets	152,825	154,828
TOTAL ASSETS	741,308	793,691
CURRENT LIABILITIES:
Accounts payable, including related party payables of $310,192 and $298,903 at March 31, 2023 and December 31, 2022, respectively	1,180,553	1,401,934
Accrued expenses, other, including interest due to related party of $3,315,152 and $3,031,112 at March 31, 2023 and December 31, 2022, respectively	4,341,058	4,018,588
Accrued compensation and related benefits	2,311,812	2,281,414
Customer deposits	306,077	305,957
Advance payment received for convertible note	15,000	15,000
Advance payment received for purchase of common stock	0	30,000
Notes payable to related parties	3,069,458	2,410,499
Current portion of deferred revenue	236,156	248,656
Note payable - due within one year	376,000	376,000
Convertible notes payable, net of unamortized discount and debt costs of $43,562 and $68,219, respectively	1,867,536	1,986,631
Total Current Liabilities	13,703,650	13,074,679
Notes payable - due after one year	150,000	150,000
Total Liabilities	13,853,650	13,224,679
STOCKHOLDERS' DEFICIT
Preferred stock, undesignated; $0.01 par value; 6,130,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $0.01 par value; 1,100,000,000 shares authorized; 18,691,770 and 10,619,331 shares issued and 18,691,141 and 10,618,702 shares outstanding at March 31, 2023 and December 31, 2022, respectively	186,918	106,193
Common stock to be issued, 1,500,000 and 1,000,000 shares, respectively	147,000	10,000
Capital in excess of par value	52,294,620	51,189,596
Accumulated deficit	(64,278,767)	(62,274,665)
Stockholders' Equity Before Treasury Stock	(11,650,229)	(10,968,876)
Treasury stock at cost, 629 shares at March 31, 2023 and December 31, 2022, respectively	(1,462,112)	(1,462,112)
Total Stockholders' Deficit	(13,112,341)	(12,430,988)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	741,309	793,691
Series A Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Preferred stock, undesignated; $0.01 par value; 6,130,000 shares authorized; no shares issued and outstanding	0	0
Series B Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Preferred stock, undesignated; $0.01 par value; 6,130,000 shares authorized; no shares issued and outstanding	0	0
Series C Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Preferred stock, undesignated; $0.01 par value; 6,130,000 shares authorized; no shares issued and outstanding	0	0
Series D Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Preferred stock, undesignated; $0.01 par value; 6,130,000 shares authorized; no shares issued and outstanding	0	0
Series E Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Preferred stock, undesignated; $0.01 par value; 6,130,000 shares authorized; no shares issued and outstanding	0	0
Series F Preferred Stock [Member]
STOCKHOLDERS' DEFICIT
Preferred stock, undesignated; $0.01 par value; 6,130,000 shares authorized; no shares issued and outstanding	$ 0	$ 0

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Statement [Line Items]
Common stock, shares par value	$ 0.01	$ 0.01
Common stock, shares authorized	1,100,000,000	1,100,000,000
Common stock, shares issued	18,691,770	10,619,331
Common stock, shares outstanding	18,691,141	10,618,702
Treasury stock shares	629	629
Related party payables included in accounts payable	$ 310,192	$ 298,903
Note payable - due within one year, net of unamortized discount and debt costs	43,562	68,219
Interest payable, related party included in accrued expenses	$ 3,315,152	$ 3,031,112
Common stock, shares To Be issued	1,500,000	1,000,000
Series B Preferred Stock [Member]
Statement [Line Items]
Preferred stock, shares par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	10	10
Preferred stock, shares outstanding	10	10
Series C Preferred Stock [Member]
Statement [Line Items]
Preferred stock, shares par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series D Preferred Stock [Member]
Statement [Line Items]
Preferred stock, shares par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series E Preferred Stock [Member]
Statement [Line Items]
Preferred stock, shares par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	250,000	250,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series F Preferred Stock [Member]
Statement [Line Items]
Preferred stock, shares par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	1,500,000	1,500,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred Stock Undesignated [Member]
Statement [Line Items]
Preferred stock, shares par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	6,130,000	6,130,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Preferred Stock Series A [Member]
Statement [Line Items]
Preferred stock, shares par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
REVENUE
Sales	$ 288,557	$ 43,195
Royalty and license fees	12,500	12,500
Revenue	301,057	55,695
COST OF GOODS SOLD	269,343	52,440
GROSS MARGIN	31,714	3,255
OPERATING EXPENSES
Research and development, net of government grant proceeds of $0 and $0 for the three months ended March 31, 2023 and 2022, respectively	134,135	64,873
Selling, general and administrative	379,400	425,276
TOTAL OPERATING EXPENSES	513,535	490,149
LOSS FROM OPERATIONS	(481,821)	(486,894)
OTHER INCOME (EXPENSE)
Interest expense	(675,040)	(595,636)
Loss on conversion of debt	(847,241)	0
TOTAL OTHER INCOME (EXPENSE), NET	(1,522,281)	(595,636)
NET INCOME (LOSS)	$ (2,004,102)	$ (1,082,530)
NET LOSS PER COMMON SHARE, BASIC AND DILUTED	$ (0.13)	$ (0.12)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED	15,394,933	9,414,796

CONDENSED STATEMENT OF STOCKHOL

CONDENSED STATEMENT OF STOCKHOLDERS DEFICIT (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement [Line Items]
Balance, amount	$ (12,430,988)	$ (8,372,175)
Net loss	(2,004,102)	(1,082,530)
Reissuance of cancelled shares, amount	0
Shares issued for conversion of debt and finance cost, amount	1,004,854
Shares to be issued for finance cost	196,000
Shares issued for finance cost, amount	0
Cashless exercise of warrant, amount	0
Shares issued for cash, amount	30,000
Shares issued for services, amount	13,500
Warrants issued as financing cost	78,395
Balance, amount	$ (13,112,341)	$ (9,454,705)
Preferred Stock
Statement [Line Items]
Balance, shares	10
Balance, amount	$ 0
Net loss	0
Reissuance of cancelled shares, amount	0
Shares issued for conversion of debt and finance cost, amount	0
Shares to be issued for finance cost	0
Shares issued for finance cost, amount	0
Cashless exercise of warrant, amount	0
Shares issued for cash, amount	0
Shares issued for services, amount	0
Warrants issued as financing cost	$ 0
Balance, shares	10
Balance, amount	$ 0
Common Stock
Statement [Line Items]
Balance, shares	10,619,331	9,415,425
Balance, amount	$ 106,193	$ 94,154
Net loss	$ 0	$ 0
Reissuance of cancelled shares, shares	1,000,000
Reissuance of cancelled shares, amount	$ 10,000
Shares issued for conversion of debt and finance cost, shares	5,344,939
Shares issued for conversion of debt and finance cost, amount	$ 53,450
Shares to be issued for finance cost	$ 0
Shares issued for finance cost, shares	500,000
Shares issued for finance cost, amount	$ 5,000
Cashless exercise of warrant, shares	577,500
Cashless exercise of warrant, amount	$ 5,775
Shares issued for cash, shares	200,000
Shares issued for cash, amount	$ 2,000
Shares issued for services, shares	450,000
Shares issued for services, amount	$ 4,500
Warrants issued as financing cost	$ 0
Balance, shares	18,691,770	9,415,425
Balance, amount	$ 186,918	$ 94,154
Comman Stock To Be Issued [Member]
Statement [Line Items]
Balance, amount	10,000	0
Net loss	0	0
Reissuance of cancelled shares, amount	(10,000)
Shares issued for conversion of debt and finance cost, amount	0
Shares to be issued for finance cost	196,000
Shares issued for finance cost, amount	(49,000)
Cashless exercise of warrant, amount	0
Shares issued for cash, amount	0
Shares issued for services, amount	0
Warrants issued as financing cost	0
Balance, amount	147,000	0
Capital in Excess of Par Value
Statement [Line Items]
Balance, amount	51,189,596	50,818,885
Net loss	0	0
Reissuance of cancelled shares, amount	0
Shares issued for conversion of debt and finance cost, amount	951,404
Shares to be issued for finance cost	0
Shares issued for finance cost, amount	44,000
Cashless exercise of warrant, amount	(5,775)
Shares issued for cash, amount	28,000
Shares issued for services, amount	9,000
Warrants issued as financing cost	78,395
Balance, amount	52,294,620	50,818,885
Retained Earnings (Accumulated Deficit)
Statement [Line Items]
Balance, amount	(62,274,665)	(57,823,102)
Net loss	(2,004,102)	(1,082,530)
Reissuance of cancelled shares, amount	0
Shares issued for conversion of debt and finance cost, amount	0
Shares to be issued for finance cost	0
Shares issued for finance cost, amount	0
Cashless exercise of warrant, amount	0
Shares issued for cash, amount	0
Shares issued for services, amount	0
Warrants issued as financing cost	0
Balance, amount	(64,278,767)	$ (58,905,632)
Redeemable Convertible Preferred Stock And Share [Member]
Statement [Line Items]
Balance, shares		10
Balance, amount		$ 0
Net loss		$ 0
Balance, shares		10
Balance, amount		$ 0
Treasury Stock And Share
Statement [Line Items]
Balance, amount	(1,462,112)	(1,462,112)
Net loss	0	0
Reissuance of cancelled shares, amount	0
Shares issued for conversion of debt and finance cost, amount	0
Shares to be issued for finance cost	0
Shares issued for finance cost, amount	0
Cashless exercise of warrant, amount	0
Shares issued for cash, amount	0
Shares issued for services, amount	0
Warrants issued as financing cost	0
Balance, amount	$ (1,462,112)	$ (1,462,112)

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,004,102)	$ (1,082,530)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization	7,605	6,682
Stock based compensation	13,500	0
Non-cash interest expenses	317,695	0
Amortization of debt discount	24,657	405,123
Loss on conversion of debt	847,241	0
(Increase) decrease in:
Accounts receivable	131,092	29,080
Inventory	(42,020)	(43,207)
Reimbursements receivable	(36,743)	0
Prepaid expenses/Other assets	6,881	(54,698)
Increase (decrease) in:
Accounts payable	(221,381)	4,400
Accrued expenses	361,477	43,342
Customer deposits	120	46,001
Deferred revenue	(12,500)	(12,500)
Net cash used in operating activities	(606,478)	(658,307)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(1,675)	(26,435)
Increase in patent costs	(3,020)	(8,049)
Net cash used in investing activities	(4,695)	(34,484)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from notes payable - related parties	970,910	0
Repayment of notes payable - related parties	(350,000)	0
Net cash provided by financing activities	620,910	0
Net increase (decrease) in cash	9,737	(692,791)
Cash, beginning of period	27,412	773,423
Cash, end of period	37,149	80,632
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	0	154,398
NON-CASH FINANCING AND FINANCING ACTIVITIES
Issuance of common stock upon conversion of notes	1,004,853	0
Notes and accrued interest settled with common stock	152,362	0
Common stock issued, proceeds received in prior year	30,000	0
Fair value of warrant, recorded as finance cost	78,395	0
Common stock to be issued for finance cost	196,000	0
Finance cost deducted from related party note	$ 38,050	$ 0

Background Information

Background Information	3 Months Ended
	Mar. 31, 2023
Background Information
Background Information	Note 1. Background Information Dais Corporation (“Dais”, “us,” “we,”, the “Company”), a New York corporation, is a nano-structured polymer technology materials company having developed and now commercializing products using its family of nanomaterial called Aqualyte. Aqualyte itself is the first product being commercialized. The second commercial product is called ConsERV, a fixed plate energy recovery ventilator which we believe is useful in meeting building indoor fresh air requirements while saving energy and lowering emissions for most forms of heating, ventilation, and air conditioning (HVAC) equipment. The Company was incorporated in April 1993 and its corporate headquarters is in Odessa, Florida. The Company is dependent on third parties to manufacture the key components needed for its nanostructured materials and some portion of the value-added products made with these materials. Accordingly, a suppliers’ failure to supply components in a timely manner, or to supply components that meet the Company’s quality, quantity and cost requirements or technical specifications, or the inability to obtain alternative sources of these components on a timely basis or on acceptable terms, would create delays in production of the Company’s products and/or increase its unit costs of production. Certain of the components or the processes of the Company’s suppliers are proprietary. If the Company was ever required to replace any of its suppliers, it should be able to obtain comparable components from alternative suppliers at comparable costs, but this would create a delay in production and may briefly affect the Company’s operations. Basis of Presentation The Company’s accompanying condensed financial statements are unaudited, but in the opinion of management reflect all adjustments necessary to fairly state the Company’s financial position, results of operations, stockholders’ deficit and cash flows as of and for the dates and periods presented. The financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information. The unaudited financial statements and notes are presented as permitted by Form 10-Q. Accordingly, certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted although the Company generally believes that the disclosures are adequate to ensure that the information presented is not misleading. The accompanying financial statements and notes should be read in conjunction with the audited financial statements and notes of the Company for the fiscal year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 30, 2023. The results of operations for the three-month period ended March 31, 2023 are not necessarily indicative of the results that may be expected for any future quarters or for the entire year ending December 31, 2023.

Going Concern and Managements P

Going Concern and Managements Plans	3 Months Ended
	Mar. 31, 2023
Going Concern and Managements Plans
Going Concern and Management's Plans	Note 2. Going Concern and Management’s Plans The accompanying financial statements have been prepared assuming the Company will continue as a going concern. For the three months ended March 31, 2023, the Company generated a net loss of $2,004,102 and has incurred significant losses since inception. As of March 31, 2023, the Company has an accumulated deficit of $64,278,767, total stockholders’ deficit of $13,112,341, negative working capital of $13,146,660 and cash and cash equivalents of $37,149. The Company used $606,478 and $658,307 of cash for operations during the three months ended March 31, 2023, and 2022, respectively, which was funded primarily by proceeds from loans from related parties and others. There is no assurance that any such financing will be available in the future. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company is currently pursuing the following sources of short and long-term working capital: 1. The Company guided by its Financial Advisors is actively working with targeted third parties who have or are interested in licensing, purchasing the rights to, or establishing a joint venture to commercialize applications of the Company’s technology; 2. The Company continues to seek capital from key strategic and/or government (grant) related sources. These sources may, pursuant to any agreements that may be developed in conjunction with such funding, assist in the product definition and design, roll-out, and channel penetration of products; 3. The Company is actively working with newer investors, private equity companies, purchase order financing parties, and its existing debt holders to restructure its existing debt and obtain short and long-term working and growth capital; and, 4. The Company may license or sell an asset to fund its continued growth as it is clear to management the market for the Company’s product innovations has changed in a positive way as demonstrated by the interest the Company’s nano-material and applications in certain markets. Management believes: 1. The Company’s ability to solve continuing supply chain issues and raise sustainable growth capital will dictate future revenue and cash-flow for the Company. The quicker these issues are resolved we believe the faster the Company can participate in the market’s uptick momentum and follow the projected growth curve. These issues place heavy pressure on management to progress in key business areas being impacted. Continued supply chain impacts has roots in the funding challenges. The use of funds from affordable growth capital to resolve inventory levels of hard to acquire parts could be achieved within one quarter. Raising affordable capital is tied to addressing/fixing convertible debt transactions (recently found to be ‘criminally usurious - (Adar Bays, LLC v. GeneSYS ID, Inc.) used in the past to grow the Company with a plan to replace this convertible debt with lower cost funds. The Company has made progress yet still faces a worldwide public market in turmoil since February of 2022. In the intertest of expediting this situation the Company is seeking affordable public, and non-public, growth resources, with Board approval, is seeking to monetize one asset via a license/supply agreement. Such a plan (monetize an asset) will require approval by the Company’s Senior Secured Noteholder. 2. The Senior Secured Note Holder has advised Management it is exploring its options to resolve the long standing unpaid – and growing debt by the Company. 3. Ventilation is regularly recommended as one of the solutions to Covid related mitigation and the market awareness for the ConsERV product(s) is increasing and lead activity is encouraging. 4. We believe our current cash position and our projected ability to obtain additional sources of growth capital, and to generate sustainable cash flow from operations and investments into 2023 is improving yet remains challenged. We believe the Company’s prospects to secure growth funding remain good. On a macro level we believe the world-wide market for equipment the type the Company is selling (and developing) has changed for the positive in the last two years reflecting end user awareness of the need to address Climate Change related issues faster, and the changes in buying habits forged by the world-wide pandemic. On more of a micro level the company has shown solid progress over the last three quarters, removed a serious impediment to growth by completing a ‘debt to equity’ program where the convertible noteholders debt positions were converted into equity (common stock and warrants). The company introduced a popular new line of our ConsERV equipment having improved performance and pricing to a growing independent sales channel through-out North America. We reached agreement (now moving to contract stage) in late 4Q 2022 between the company and its Senior Secured Note Holder (having deep rights with the assets of the Company which are pledged as security for repayment of the Note). The company is continuing to develop the basis of a long-term business relationship with a well-known, multi-national corporation interested in using the Company’s HVAC and water products for its own and third-party use. There are no assurances we will be able to obtain the financing and planned product development commercialization. Accordingly, we may not have the ability to continue as a going concern. The financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should we be unable to continue as a going concern.

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Significant Accounting Policies
Significant Accounting Policies	Note 3. Significant Accounting Policies The significant accounting policies followed are: Use of estimates - Significant estimates underlying the Company’s reported financial position and results of operations include the allowance for doubtful accounts, fair value of stock-based compensation, fair value of derivative liabilities, valuation allowance on deferred taxes and the warranty reserve. Revenue recognition - In certain instances, the Company’s ConsERV system product may carry a limited warranty of up to one year for all parts contained therein except for the energy recovery ventilator core produced and sold by the Company. The distributor of the ConsERV system may carry a limited warranty of up to ten years. The limited warranty includes replacement of defective parts for the ConsERV system and includes workmanship and material failure for the ConsERV core. The Company recorded an accrual of $91,531 for future warranty expenses at March 31, 2023 and December 31, 2022, which is included in accrued expenses, other. Royalty revenue is recognized as earned. The Company recognized royalty revenue of $0 for the three months ended March 31, 2023 and 2022, respectively. Revenue derived from the sale of licenses is deferred and recognized as license fee revenue on a straight-line basis over the life of the license, or until the license arrangement is terminated. The Company recognized license fee revenue of $12,500 and $12,500 for the three months ended March 31, 2023 and 2022, respectively. The Company accounts for revenue arrangements with multiple elements under the provisions of the Financial Accounting Standards Boards (FASB) Accounting Standards Codification (ASC) Topic 605-25, “Revenue Recognition-Multiple-Element Arrangements.” In order to account for these agreements, the Company must identify the deliverables included within the agreement and evaluate which deliverables represent separate units of accounting based on if certain criteria are met, including whether the delivered element has stand-alone value to the licensee. The consideration received is allocated among the separate units of accounting, and the applicable revenue recognition criteria are applied to each of the separate units. In December 2017, the Company and Zhejiang MENRED Environmental Tech Co, Ltd., Zhejiang Province, China (“Menred”), entered into a License and Supply Agreement (the “Agreement”), effective December 21, 2017. Pursuant to the Agreement, the Company licensed certain intellectual property and improvements to Menred, for use in the manufacture and sale of energy recovery ventilators (“ERV”) and certain other HVAC systems for installation in commercial, residential, or industrial buildings in China. Menred also agreed to purchase its requirements of certain products from the Company for Menred’s use, pursuant to the terms and conditions of the Agreement. Menred will also pay royalties, as defined, to the Company on a quarterly basis, based on price and production volume as provided by Menred. No royalties are due within the first year of the Agreement. Also pursuant to the Agreement, the Company is required to purchase a certain amount of Product from Menred. The Agreement has a ten-year term with mutually agreed upon five-year extensions. Cash and cash equivalents - Concentrations - Fair Value of Financial Instruments - Inventory - Property and equipment - Intangible assets Research and development expenses and funding proceeds - Earnings (loss) per share Recent Accounting Pronouncements -

Accrued Expenses Other

Accrued Expenses Other	3 Months Ended
	Mar. 31, 2023
Accrued Expenses Other
Accrued Expenses, Other	Note 4. Accrued Expenses, Other Accrued expenses, other consists of the following: March 31, December 31, 2023 2022 Accrued expenses, other $ 671,649 $ 673,270 Accrued interest 3,577,878 3,253,787 Accrued warranty costs 91,531 91,531 $ 4,341,058 $ 4,018,588

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2023
Related Party Transactions
Related Party Transactions	Note 5. Related Party Transactions The Company rents a building that is owned by two stockholders of the Company, one of which is the Chief Executive Officer. Rent expense for this building is $4,066 per month, including sales tax. The Company recognized rent expense (including property tax charges) related to this lease of $12,198 and $12,198 for the three months ended March 31, 2023 and 2022, respectively. The lease term will terminate upon 30 days’ written notice from landlord or 90 days written termination from us. The lease is considered to be short term or month to month. The Company has accrued compensation due to the Chief Executive Officer as of March 31, 2023 and December 31, 2022 of $2,166,523 and $2,140,687, respectively, included in accrued compensation and related benefits in the accompanying balance sheets. On June 24, 2016, the Company entered into a Loan and Security Agreement (“Security Agreement”) with the entity known as PKT -- Strategic Assets, LLC (the “Holder”) pursuant to which the Company issued a Senior Secured Promissory Note for $150,000 (the “Note”). The Note has an interest rate is 12% per annum compounded daily with a minimum interest payment of $2,000. The Note grants the Holder a secure interest in all the assets of the Company. During 2016 to the period ended March 31, 2023, the Holder extended the Note pursuant to various amendments. Pursuant to the amendments, the principal amount and interest totaled $6,372,511 and $5,429,661 (including fees and other expenses) at March 31, 2023 and December 31, 2022, respectively. We received advances aggregating $658,960 during the three months ended March 31, 2023, and repaid $154,398 during the three months ended March 31, 2022. Financing cost of $38,050 was deducted from the 2023 advances. The Holder’s corporation is controlled by Ms. Tangredi, related to Tim Tangredi: the Company’s CEO and stockholder, and therefore, is a Related Party of the Company. The Company is to pay the Holder the principal, plus all interest and fees due in accordance with terms and conditions of the Security Agreement on the earlier of: (i) The date upon which the Company secures funds, regardless of source, equal to or exceeding, in the aggregate, $1,000,000 or November 1, 2021, which as of the date of filing, has expired. (ii) The Holder has not declared the Note in Default as the Parties have reached terms to address several issues including the extension of the Maturity Date (the “Maturity Date”). The parties have agreed to new language to solve this matter with the plan to have it complete in the third quarter of 2023. (iii) The Company has recorded interest expense of $283,890 and $149,066 for the three months ended March 31, 2023 and 2022, respectively. (iv) Accrued interest was $3,313,052 and $3,029,162 at December 31, 2022 and 2021, respectively. Of the 2023 advances, funds in the amount of $592,960 originally came from Ethos Business Ventures. It was a last minute change of plan to assist the Company meet its obligations in a timely manner. This last minute change was made necessary by an administrative error at the bank of PKT Strategic Assets, LLC. who was to have been the lender of record, and is the lender of the Company's senior secured promissory note and security agreement. To correct this error, management of Dais (with BOD approval), Ethos, and PKT agreed on April 3, 2023 effective immediately the ownership of the $592,960 sum will be transferred to PKT Strategic Assets, LLC at no cost or term and condition alteration except as it pertains to relevant language to effect the change in ownership. The definitive paperwork will be complete in 3Q 2023. Dais is to pay a minimum of $6,000 per month in interest only to PKT Strategic Assets, LLC. This change will be fully reported in 3Q 2023 Form 10Q. On October 12, 2019, the Company entered a promissory note with an entity controlled by our Chief Executive Officer in the amount of $10,000. The note bears interest at 10% per year and matured on October 12, 2021. Interest expense on the note was $150 for each of the three months ended March 31, 2023 and 2022. Accrued interest was $2,100 and $1,950 at March 31, 2023 and December 31, 2022, respectively. The Holder has not declared the Note in Default or extended the Maturity Date. On April 29, 2022, the Company received a loan of $100,000 from its Chief Executive Officer. This was repaid in full on May 17, 2022. On February 27, 2015, the Company, and Tim N. Tangredi, the Company’s Chief Executive Officer entered an amendment (the “Tangredi Employment Agreement Amendment”) to Mr. Tangredi’s Amended and Restated Employment Agreement. Currently, the Company has non-interest-bearing accrued compensation due to the Chief Executive Officer for deferred salaries earned and unpaid as described above. The Tangredi Employment Agreement Amendment provides that, if at any time during a calendar year, the unpaid compensation is greater than $500,000, Mr. Tangredi must convert $100,000 of unpaid compensation into the Company’s common stock during such calendar year. The conversion rate shall be equal to 75% of the average closing price for the Company’s common stock for the 30 trading days prior to the date of conversion. The Company shall also pay to Mr. Tangredi a cash payment equal to 20% of the compensation income incurred because of the change. The Company has waived the conversion requirement from 2015 to the present. Further, at any time any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934) becomes the “beneficial owner” (as defined in Rules 13(d)-3 and 13(d)-5 under such Act) of greater of 40% of the then-outstanding voting power of the voting equity interests of the Company or a person or group initiate a tender offer for the Company’s common stock, Mr. Tangredi may convert unpaid compensation into Class A Convertible Preferred Stock (“Class A Preferred Stock”) of the Company at a conversion price of $1.50 per share. The Board of Directors waived the requirement to convert $100,000 of unpaid compensation into common stock during 2016. No amounts have been converted under the terms of the Tangredi Employment Agreement Amendment to date. On January 27, 2022, the Board approved the distribution of Series F Convertible Preferred Warrants to Board members, the Dais Team, and those contractually bound to receive these warrants on January 27, 2022. These new Series were approved by NYS Division of Corporations on March 23, 2022. The above terms and amounts are not necessarily indicative of the terms and amounts that would have been incurred had comparable transactions been entered into with independent parties.

Equity Transactions

Equity Transactions	3 Months Ended
	Mar. 31, 2023
Equity Transactions
Equity Transactions	Note 6. Equity Transactions Preferred Stock At March 31, 2023 and December 31, 2022, the Company’s Board of Directors authorized 10,000,000 shares of preferred stock with a par value of $0.01 to be issued in series with terms and conditions to be determined by the Board of Directors. 2,000,000 of the shares of preferred stock has been designated as Class A Preferred Stock. The Class A Preferred Stock shall entitle the holder thereof to 150 votes on all matters submitted to a vote of the stockholders of the Company. 10,000 of the shares of preferred stock has been designated as Class B Preferred Stock. The Class A Preferred Stock shall entitle the holder thereof to 150 votes on all matters submitted to a vote of the stockholders of the Company. The Class B Stock includes the right to vote in an amount equal to 51% of the votes to approve certain corporate actions, including, without limitation, changing the name of the Company and increasing the number of authorized shares. Upon any liquidation, dissolution or winding up of the Company, no distribution shall be made to the holders of shares of stock ranking junior (either as to dividends or upon liquidation, dissolution or winding up) to the Class A or Class B Preferred Stock unless, prior thereto, the holders of shares of Class A or Class B Preferred Stock shall have received $1.50 per share (the “Stated Amount”). The Class A and Class B Preferred Stock shall rank, with respect to the payment of liquidation, dividends and the distribution of assets, senior to the Company’s Common Stock. The Holder (as defined in the Class A Preferred Stock certificate of designations) of the Class A Preferred Stock may convert all or part of the outstanding and unpaid Stated Amount (as defined in the Class A Preferred Stock certificate of designations) into fully paid and non-assessable shares of the Company’s common stock at the Conversion Price (as defined in the Class A Preferred Stock certificate of designations). The number of shares receivable upon conversion equals the Stated Amount divided by the Conversion Price. The Conversion Price shall be equal to 75% of the average closing price for the 30 trading days prior to the election to convert. At no time will the Company convert any of the Stated Amount into common stock if that would result in the Holder beneficially owning more than 49% of the sum of the voting power of the Company’s outstanding shares of common stock plus the voting power of the Class A Preferred Stock. No shares of Class A Preferred Stock have been issued. The shares of the Class B Preferred Stock shall be automatically redeemed by the Company at $0.01 per share on the date that Tim N. Tangredi ceases, for any reason, to serve as an officer, director, or consultant of the Company. During January and February 2022, after the Company’s fiscal year ended December 31, 2021, the Company’s Board of Directors, with input from the Company’s financial advisors, completed its reevaluation of the Company’s capital structure, including the advisability of authorizing addition series of preferred stock, par value $0.01 (“Preferred Stock”). The Board of Directors determined that it was in the best interests of the Company and its stockholders to authorize four new series of Preferred Stock (sometimes referred to as “New Series of Preferred Stock”). As a result, the Board of Directors and management with the assistance of its outside financial advisors prepared a Certificate of Amendment to its Certificate of Incorporation for the purpose authorizing the four New Series of Preferred Stock, which was subject to the filing by the Company of a Certificate of Amendment with the Department of State of the State of New York (“Certificate of Amendment”). To implement the authorization of the four New Series of Preferred Stock, the Certificate of Amendment was submitted to the Department of State on March 17, 2022, and was accepted for filing on March 22, 2022. The recently authorized New Series of Preferred Stock included: (i) Series C Convertible Preferred Stock, consisting of 100,000 shares, all of which were to be issued following acceptance of the Certificate of Amendment by the Department of State, to two (2) third-party accredited investors who had provided bona fide financial consulting services to the Company; (ii) Series D Convertible Preferred Stock, consisting of 10,000 shares, which shares may be issued, at the sole discretion of the Board of Directors, from time to time, to consultants and other third parties for, among other purposes, new services to the Company and for other good and valuable consideration, none of which shares have been issued; (iii) Series E Convertible Preferred Stock, consisting of 250,000 shares, all of which were to be issued following final acceptance of the Certificate of Amendment by the Department of State, being issued to three (3) “accredited investors” including the Company’s financial advisors in consideration for their capital contributions to the Company; and (iv) Series F Convertible Preferred Stock consisting of 1,500,000 shares which are intended to be issued to several long-tenured key employees and the Company’s Board of Directors in consideration for previously rendered services to the Company as well as to certain noteholders and others under agreements and arrangements that have been authorized by the Board of Directors. Issuances within Series C, and E were completed earlier in 2023, there has been no need to issue any Series D, and Series F has been agreed to and will be issued in Q3 of 2023. Common Stock At March 31, 2023 and December 31, 2022, the Company’s Board of Directors authorized 1,100,000,000 shares of common stock with a par value of $0.01 to be issued in series with terms and conditions to be determined by the Board of Directors. 2023 Common Stock Transactions During the three months ended March 31, 2023, an aggregate of 5,344,939 shares of common stock were issued upon the conversion of $143,752 of notes payable, $8,610 of related accrued interest, and $5,250 of fees. The value of the shares issued was $1,004,853, and we recorded a loss on conversion of $847,241. During 2023, we reissued 1,000,000 shares of common stock that had been cancelled in 2022. In connection with a loan received in January 2023, we agreed to issue 2,000,000 shares of common stock valued at $196,000, calculated by the open market share value on the date of the grant. As of March 31, 2023, 500,000 shares have been issued and the remaining 1,500,000 shares, valued at $147,000, are classified as Common Stock To Be Issued. During March of 2023, we issued 577,500 shares of common stock upon the cashless exercise of 733,333 warrants. During March 2023, we issued 450,000 shares of common stock, valued at $13,500, for services, calculated by the open market share value on the date of the grant. During March 2023, we issued 200,000 shares of common stock for cash. The proceeds had been advanced to the Company in December 2021. 2022 Common Stock Transactions There were no common stock transactions during the three months ended March 31, 2022. Options and Warrants In January 2023, the Company issued a warrant to purchase 800,000 shares of common stock, in connection with the amendment of a convertible note. The warrant has a term of five years and has a cash exercise price of $0.10 or a cashless exercise price of $0.20. The fair value of the warrant was $78,395, determined using the Black Scholes Model with the following assumptions: (1) risk free interest rate of 3.9% - 1.33%; (2) dividend yield of 0%; (3) volatility factor of the expected market price of the Company’s common stock of 362%; and (4) an expected life of 5 years. During March of 2023, 733,333 warrants were exercised on a cashless basis into 577,500 shares of common stock.

Convertible Notes Payable

Convertible Notes Payable	3 Months Ended
	Mar. 31, 2023
Accrued Expenses Other
Convertible Notes Payable	Note 7. Convertible Notes Payable 2022 Convertible Notes On December 12, 2022, the Company entered a convertible promissory note in the amount of $40,000. The Note was amended in January, 2023. The note matures on January 5, 2024 and bears interest at 8% per year. The note is convertible into shares of common stock at a fixed conversion price of $0.05 per share. As consideration for the amendment, the Company issued a warrant to purchase 800,000 shares of common stock. The warrant has a term of five years and has a cash exercise price of $0.10 or a cashless exercise price of $0.20. The warrant had a value of $78,395, which has been charged to finance cost. On November 4, 2022, the Company entered a convertible promissory note in the amount of $25,000. The note matures on the earlier of May 4, 2023 or 5 days after demand and bears interest at 10% per year. The note is convertible into shares of common stock at a fixed conversion price of $0.30 per share. On September 7, 2022, the Company entered a convertible promissory note in the amount of $100,000. The note matures on September 7, 2023 and bears interest at 8% per year. The note is convertible into shares of common stock at a fixed conversion price of $0.10 per share. The company has recorded a discount of $100,000. Amortization of discount was $24,658 for the three months ended March 31, 2023. On August 20, 2022, the Company entered a convertible promissory note in the amount of $49,850. The note matures on the earlier of February 20, 2023 or 10 days after demand and bears interest at 8% per year. The note is convertible into shares of common stock at a fixed conversion price of $0.30 per share. On June 15, 2022, the Company entered two convertible promissory notes aggregating $300,000. The notes mature on the earlier of December 15, 2022 or 10 days after demand and bear interest at 8% per year. The Company received proceeds of $300,000. The notes are convertible into shares of common stock at a fixed conversion price of $0.30 per share. The Company has recorded debt discount of $200,000, related to the beneficial conversion feature of the notes, which was fully amortized in 2022. 2021 Convertible Notes On September 20, 2021, the Company entered a convertible promissory note with GS Capital Partners, LLC with a face value of $220,000. The note matured on September 20, 2022 and bears interest at 8% per year. The note is convertible into shares of common stock at a fixed conversion price of $0.10 per share. The lender has not declared a default as both parties are actively discussing a mutually beneficial path forward with an agreement expected during the first quarter of 2023. This did not occur. Please see the section titled “ Subsequent Events” for more information. During the three months ended March 31, 2023, an aggregate of 2,299,000 shares of common stock were issued upon the conversion of $60,000 of notes payable, $8,610 of related accrued interest, and $3,000 of fees. The value of the shares issued was $457,921, and we recorded a loss on conversion of $386,311. During the fourth quarter of 2021, the Company entered twenty convertible promissory notes with various holders aggregating $1,412,000. The notes matured one year from issuance and bear interest at 8% per year. The notes are convertible into shares of common stock at a fixed conversion price of $0.10 per share. During the three months ended March 31, 2023, an aggregate of 3,045,939 shares of common stock were issued upon the conversion of $83,752 of notes payable and $2,250 of fees. The value of the shares issued was $546,932, and we recorded a loss on conversion of $460,930. The Company’s convertible promissory notes at March 31, 2023 and December 31, 2022 are as follows: March 31, 2023 December 31, 2022 Convertible notes payable, bearing interest at 8-10% $ 1,911,098 $ 2,054,850 Unamortized debt discount (43,562 ) (68,219 ) Unamortized deferred debt issuance cost - - Total 1,867,536 1,986,631 Current portion $ 1,867,536 $ 1,986,631

Notes Payable

Notes Payable	3 Months Ended
	Mar. 31, 2023
Notes Payable
Notes Payable	Note 8. Notes Payable JMS Investments Between April of 2021 and September 30, 2021, JMS Investments of Staten Island, NY, USA invested $376,000 in seven separate transactions. The sums are repayable in the form of one-year demand notes having an interest rate of 8.5%. GEX Management, Inc. On August 30, 2021, the Company entered into a promissory note with GEX Management, Inc. The note matured on February 28, 2022 and was repaid in December 2021. In connection with this note, the Company has agreed to issue 1,000,000 shares of common stock to the lender. These shares have not been issued at March 31, 2023. The shares have been valued at $120,990, which has been included in accrued expenses at March 31, 2023 and December 31, 2022. Small Business Administration Loan On June 12, 2020, the Company received $150,000 in a loan borrowed from the SBA. Installment payments, including principal and interest, of $731 monthly, will begin 12 months from the date of the note. The balance of principal and interest will mature 30 years from the date of the note. Interest will accrue at the rate of 3.75% per year. On March 16, 2021, the U.S. Small Business Administration announced that the deferment period for the repayment would be extended an additional 12 months. The company received a past due notice dated June 6 , 2023 for $4,386 due since December 12, of 2022 due to an error on the part of the company. The company anticipates the sum will be paid in full during the first part of the 3 rd 2023 Note On January 27, 2023, the Company received a short-term loan of $350,000. The loan was repaid in full on March 6, 2023. In connection with this loan, the Company agreed to issue 2,000,000 shares to the individual, valued at $196,000. As of March 31, 2023, 500,000 shares have been issued and the remaining 1,500,000 shares, valued at $147,000, are classified as Common Stock To Be Issued.

Deferred Revenue

Deferred Revenue	3 Months Ended
	Mar. 31, 2023
Deferred Revenue
Deferred Revenue	Note 9. Deferred Revenue In December 2017, the Company and Zhejiang MENRED Environmental Tech Co, Ltd., Zhejiang Province, China (“Menred”), entered into a royalty bearing License and Supply Agreement (the “License and Supply Agreement”), effective December 21, 2017. Pursuant to the License and Supply Agreement, the Company licensed certain intellectual property and improvements to Menred, for use in the manufacture and sale of certain product types sold by Menred mostly for installation in buildings in China. Menred also agreed to purchase its requirements of certain products from the Company for Menred’s use, pursuant to the terms and conditions of the License and Supply Agreement. Also pursuant to the License and Supply Agreement, each year the Parties have minimum sales commitments of each other’s products. The License and Supply Agreement has a ten-year term with mutually agreed upon five-year extensions. The parties began a renegotiation of the terms and conditions of this agreement in December of 2022. The Company recognized license revenue of $12,500 for each of the three months ended March 31, 2023 and 2022. Deferred revenue for the agreement was $236,156 and $248,656 at March 31, 2023 and December 31, 2022, respectively. The Company recognized royalty revenue of $0 for the three months ended March 31, 2023 and 2022.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies
Commitments and Contingencies	Note 10. Commitments and Contingencies Litigation From time to time, claims are made against the Company in the ordinary course of its business, which could result in litigation. Claims and associated litigation are subject to inherent uncertainties and unfavorable outcomes could occur, such as monetary damages, fines, penalties, or injunctions prohibiting the Company from selling one or more products or engaging in other activities. The occurrence of an unfavorable outcome in any specific period could have a material adverse effect on the Company’s results of operations for that period or future periods. In 2015, the Company commenced an action for the cancellation of shares issued to Soex (the “Shares”) in connection with a breached Securities Purchase Agreement and Distribution Agreement entered 2014. The Soex Litigation was tried in U.S. District Court for the Middle District of Florida in October of 2018. The jury at the conclusion of the trial did not award monetary damages to either party for claims or counterclaims. On October 24, 2018, the Company initiated a third lawsuit against an affiliate of Soex, Zhongshan Trans-Tech New Material Technology Co. Ltd. Zhongshan, China, (“Transtech”), and the Chairperson of the affiliate and Soex, based on new information learned by the Company. The Company will seek maximum relief and damages for this on-going and growing illegal misuse the Company’s Intellectual Property. The Company feels this third action will lead in a judgment in favor of the Company. On October 8, 2021 the Company was notified of a unusual order by the Federal District Court judge who oversaw the initial 2018 proceedings. This activity was initiated at the request of Soex’s counsel. The Order awards the defendant (Soex) $300,568 in attorney’s fees and $82,096 in costs for a total award of $382,664 to be paid by Dais. The Order doesn’t specify the date by which the award needs to be paid. The sum is recorded in accrued liabilities. The Company will vigorously defend itself against this Order, as well as move on all possible avenues open to it to stop, what Management believes is an on-going misuse of the Company’s core Intellectual Property. The Company believes - based on the content of the Order and other admissions and actions on the part of others - it has a chance to prevail in an appeal to the benefit of the Company and its shareholders. Accounts Payable The firms below have pursued legal action against the Company to collect overdue accounts payable sums. The Company is working with each to enter into a settlement plan, or “pay over a period of time” payment plan. To date the Company has one agreement in place with SoftinWay. Company Sum Owned Payment Plan Legal Action Old Dominion Freight Line (1) $ 13,575.95 No Yes Power Plant Services (2) $ 85,199.11 No Yes SoftinWay (3) $ 1,850.00 Yes Yes The O-Ring Store $ 10,334.00 No Yes Total $ 112,459.06 Footnotes for Accounts Payable Table 1. This action moved towards settlement in December of 2022 and completing in March of 2023. The sum the creditor froze $28,781 of the Company’s funds at the Company’s bank, the parties discussed the matter. The sum owed was agreed to be $17,212 including principle, interest, court costs and legal fees, and the balance being $11,569 was returned to the company on May 8, 2023 2. The sum the creditor froze $4,700 of the Company’s funds at the Company’s bank. The company is exploring post judgement relief options/taking steps to ensure that Secured Noteholders priority is protected and to negotiate an acceptable repayment plan. On June 2, 2023, the creditor obtained the frozen $4,700. Discussions are on-going with the creditor to set up a repayment plan. 3. The original balance of approximately $24,165 has been consistently paid down per a verbal repayment agreement.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events
Subsequent Events	Note 11. Subsequent Events No material events have occurred after March 31, 2023 that requires recognition or disclosure in the financial statements except as follows: On April 11, 2023 the Company received funding in the amount of $43,950 in the form of a convertible note with terms similar to past notes. On April 14, 2023 the Company issued a total of 570,000 shares of common stock in exchange for consulting services. On April 27, 2023 the Company received funding in the amount of $25,000 in the form of a convertible note with terms similar to past notes. On April 27, 2023 the Company issued 887,595 shares of common stock in relation to conversions on convertible notes payable. On April 28, 2023 the Company received funding in the amount of $100,000 in the form of a convertible note with terms similar to past notes. On March 24, 2023 a filing was made in the 2 nd On May 2, 2023 the Company received notice the garnishment to repay Old Dominion Trucking had been fully satisfied. On June 2, 2023 the Company receive notice from Alin Machining Company (Power Plant Services) restating the sum owed of $84,681 plus interest from entry of judgement in foreign court (Cook County, IL) on February 11, 2021. On June 2, 2023 the Company received funding in the amount of $195,000. There is a payment due weekly on this note. To date, the company has repaid $11,259 On June 20, 2023 the Company received funding in the amount of $150,000 as an addition to the Senior Secured Note. As of the day of filing, the Company has repaid $12,000 in interest towards the Senior Secured Note. No other material events have occurred after March 31, 2023, requiring recognition or disclosure in the financials.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Significant Accounting Policies
Use of estimates	Use of estimates - Significant estimates underlying the Company’s reported financial position and results of operations include the allowance for doubtful accounts, fair value of stock-based compensation, fair value of derivative liabilities, valuation allowance on deferred taxes and the warranty reserve.
Revenue recognition	Revenue recognition - In certain instances, the Company’s ConsERV system product may carry a limited warranty of up to one year for all parts contained therein except for the energy recovery ventilator core produced and sold by the Company. The distributor of the ConsERV system may carry a limited warranty of up to ten years. The limited warranty includes replacement of defective parts for the ConsERV system and includes workmanship and material failure for the ConsERV core. The Company recorded an accrual of $91,531 for future warranty expenses at March 31, 2023 and December 31, 2022, which is included in accrued expenses, other. Royalty revenue is recognized as earned. The Company recognized royalty revenue of $0 for the three months ended March 31, 2023 and 2022, respectively. Revenue derived from the sale of licenses is deferred and recognized as license fee revenue on a straight-line basis over the life of the license, or until the license arrangement is terminated. The Company recognized license fee revenue of $12,500 and $12,500 for the three months ended March 31, 2023 and 2022, respectively. The Company accounts for revenue arrangements with multiple elements under the provisions of the Financial Accounting Standards Boards (FASB) Accounting Standards Codification (ASC) Topic 605-25, “Revenue Recognition-Multiple-Element Arrangements.” In order to account for these agreements, the Company must identify the deliverables included within the agreement and evaluate which deliverables represent separate units of accounting based on if certain criteria are met, including whether the delivered element has stand-alone value to the licensee. The consideration received is allocated among the separate units of accounting, and the applicable revenue recognition criteria are applied to each of the separate units. In December 2017, the Company and Zhejiang MENRED Environmental Tech Co, Ltd., Zhejiang Province, China (“Menred”), entered into a License and Supply Agreement (the “Agreement”), effective December 21, 2017. Pursuant to the Agreement, the Company licensed certain intellectual property and improvements to Menred, for use in the manufacture and sale of energy recovery ventilators (“ERV”) and certain other HVAC systems for installation in commercial, residential, or industrial buildings in China. Menred also agreed to purchase its requirements of certain products from the Company for Menred’s use, pursuant to the terms and conditions of the Agreement. Menred will also pay royalties, as defined, to the Company on a quarterly basis, based on price and production volume as provided by Menred. No royalties are due within the first year of the Agreement. Also pursuant to the Agreement, the Company is required to purchase a certain amount of Product from Menred. The Agreement has a ten-year term with mutually agreed upon five-year extensions.
Cash and cash equivalents	Cash and cash equivalents -
Concentrations	Concentrations -
Fair Value of Financial Instruments	Fair Value of Financial Instruments -
Inventory	Inventory -
Property and equipment	Property and equipment -
Intangible assets	Intangible assets
Research and development expenses and funding proceeds	Research and development expenses and funding proceeds -
Earnings (loss) per share	Earnings (loss) per share
Recent Accounting Pronouncements	Recent Accounting Pronouncements -

Accrued Expenses Other (Tables)

Accrued Expenses Other (Tables)	3 Months Ended
	Mar. 31, 2023
Accrued Expenses Other
Schedule of accrued expenses, other	March 31, December 31, 2023 2022 Accrued expenses, other $ 671,649 $ 673,270 Accrued interest 3,577,878 3,253,787 Accrued warranty costs 91,531 91,531 $ 4,341,058 $ 4,018,588

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2023
Accrued Expenses Other
Schedule of convertible notes payable	March 31, 2023 December 31, 2022 Convertible notes payable, bearing interest at 8-10% $ 1,911,098 $ 2,054,850 Unamortized debt discount (43,562 ) (68,219 ) Unamortized deferred debt issuance cost - - Total 1,867,536 1,986,631 Current portion $ 1,867,536 $ 1,986,631

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies
Schedule of pursued legal action	Company Sum Owned Payment Plan Legal Action Old Dominion Freight Line (1) $ 13,575.95 No Yes Power Plant Services (2) $ 85,199.11 No Yes SoftinWay (3) $ 1,850.00 Yes Yes The O-Ring Store $ 10,334.00 No Yes Total $ 112,459.06

Going Concern and Managements_2

Going Concern and Managements Plans (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Going Concern and Managements Plans
Net income (loss)	$ (2,004,102)
Accumulated deficit	(64,278,767)		$ (62,274,665)
Total stockholders' deficit	(13,112,341)
Working capital deficit	(13,146,660)
Net cash used in operating activities	606,478	$ 658,307
Cash and cash equivalents	$ 37,149

Significant Accounting Polici_3

Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Statement [Line Items]
Anti-dilutive common shares	29,508,645	32,526,731
Royalty revenues	$ 0	$ 0
License fees revenue	12,500	12,500
Inventory raw materials	303,038		$ 269,083
Inventory in process	33,454		5,997
Inventory finished goods	0		19,392
Depreciation expense	2,582	1,851
Research and development expenses	$ 134,135	$ 64,873
Accounts Receivable [Member] | Four Customers [Member]
Statement [Line Items]
Concentration of risk	85%
Accounts Receivable [Member] | Two Customers [Member]
Statement [Line Items]
Concentration of risk		76%
Revenue [Member] | Four Customers [Member]
Statement [Line Items]
Concentration of risk	55%	83%
Leasehold Improvements [Member]
Statement [Line Items]
Property and equipment estimated useful life	5 years
Minimum [Member]
Statement [Line Items]
Property and equipment estimated useful life	3 years
Maximum [Member]
Statement [Line Items]
Property and equipment estimated useful life	7 years
Intangible Assets [Member]
Statement [Line Items]
Estimated useful lives of patents	17 years
Patents [Member]
Statement [Line Items]
Amortization expense	$ 5,023	$ 4,831
Future amortization expense, 2022			$ 20,000

Accrued Expenses Other (Details

Accrued Expenses Other (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Accrued Expenses Other
Accrued expenses, other	$ 671,649	$ 673,270
Accrued interest	3,577,878	3,253,787
Accrued warranty costs	91,531	91,531
Total accrued expenses	$ 4,341,058	$ 4,018,588

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)		1 Months Ended			3 Months Ended
	Oct. 12, 2019	Apr. 29, 2022	Jun. 24, 2016	Feb. 27, 2015	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Statement [Line Items]
Rent expense					$ 12,198	$ 12,198
Lease term description					The lease term will terminate upon 30 days’ written notice from landlord or 90 days written termination from us. The lease is considered to be short term or month to month
Financing cost					$ 38,050
Interest expense					283,890	149,066
Accrued interest							$ 3,313,052	$ 3,029,162
Ethos Business Ventures
Statement [Line Items]
Advanced amount					592,960
Ownership amount					592,960
Interest expense					6,000
...Building [Member]
Statement [Line Items]
Monthly rent expense					4,066
Chief Executive Officer [Member]
Statement [Line Items]
Interest expense					150	150
Promissory note	$ 10,000
Accrued compensation					2,166,523		2,140,687
Interest Bearing Per Year	10%
Debt instrument maturity date	Oct. 12, 2021
Received loan		$ 100,000
Accrued interest					2,100		1,950
Patricia Tangredi [Member] | Loan And Security Agreement [Member]
Statement [Line Items]
Received advances aggregating					658,960	$ 154,398
Principal amount and interest totaled					$ 6,372,511		$ 5,429,661
Debt instrument maturity date			Nov. 01, 2021
Interest rate			12%
Senior secured promissory note			$ 150,000
Senior secured debt, minimum interest payment			2,000
Exceeding amount			$ 1,000,000
Mr. Tangredi [Member]
Statement [Line Items]
Conversion price				$ 1.50
Unpaid compensation				$ 500,000
Unpaid compensation convert into common stock amount				$ 100,000
Conversion rate				75%
Percentage of cash payment compensation income				20%
Converted unpaid compensation into common stock				$ 100,000
Mr. Tangredi [Member] | Class A Convertible Preferred Stock [Member]
Statement [Line Items]
Beneficial owner description				greater of 40% of the then-outstanding voting power of the voting

Equity Transactions (Details Na

Equity Transactions (Details Narrative)		3 Months Ended
	Apr. 14, 2023 shares	Mar. 31, 2023 USD ($) integer $ / shares shares	Mar. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares
Statement [Line Items]
Common stock value | $		$ 186,918		$ 106,193
Common stock shares authorized		1,100,000,000		1,100,000,000
Common stock, par value | $ / shares		$ 0.01		$ 0.01
Common stock shares issued for service	570,000	1,500,000
Loss on conversion | $		$ 847,241
Board of Directors [Member]
Statement [Line Items]
Preferred stock, shares par value | $ / shares		$ 0.01		$ 0.01
Preferred stock shares authorized		10,000,000		10,000,000
Common stock, par value | $ / shares		$ 0.01
Convertible Note [Member]
Statement [Line Items]
Number of warrant exercised		577,500
Issued of warrant purchase		800,000
Fair value of warrants | $		$ 78,395
Risk free interest rate		362%
Expected life		5 years
Dividend yield		0%
Warrants issued		733,333
Warrants, per share price | $ / shares		$ 0.10
Volatility rate, Minimum		3.90%
Volatility rate, Maximum		1.33%
Options and Warrants [Member]
Statement [Line Items]
Expiry of warrant			800,000
Number of warrant exercised		733,333	733,333
Fair value of warrants | $		$ 78,395	$ 78,395
Risk free interest rate minimum		3.90%	3.90%
Risk free interest rate maximum		1.33%
Volatility rate		362%	362%
Expected life		5 years	5 years
Dividend yield		0%	0%
Warrants, per share price | $ / shares		$ 0.10	$ 0.10
Warrants, exercise price | $ / shares		$ 0.20	$ 0.20
Warrants [Member]
Statement [Line Items]
Number of warrant exercised		577,500	577,500
Exercise price | $ / shares		$ 450,000
Common stock shares issued for service		2,000,000
Common Stock Transactions [Member]
Statement [Line Items]
Common stock value | $		$ 1,004,853
Expiry of warrant		5,344,939
Number of warrant exercised		5,344,939
Conversion of notes payable | $		$ 143,752
Accrued interest, | $		$ 8,610
Issued of warrant purchase		577,500
fees | $		$ 5,250
Common stock shares issued for service		13,500
Series A Preferred Stock [Member]
Statement [Line Items]
Preferred stock, shares par value | $ / shares		$ 0.01		$ 0.01
Preferred stock shares authorized		2,000,000
Preferred stock, number of votes | integer		150
Conversion price description		The Conversion Price shall be equal to 75% of the average closing price for the 30 trading days prior to the election to convert
Per share | $ / shares		$ 1.50
Voting power		49%
Series B Preferred Stock [Member]
Statement [Line Items]
Preferred stock, shares par value | $ / shares		$ 0.01		$ 0.01
Preferred stock shares authorized		10,000		10,000
Voting right description		equal to 51% of the votes to approve certain corporate actions, including, without limitation, changing the name of the Company and increasing the number of authorized shares
Preferred stock, number of votes | integer		150
Series C Preferred Stock [Member]
Statement [Line Items]
Preferred stock, shares par value | $ / shares		$ 0.01		$ 0.01
Preferred stock shares authorized		100,000		100,000
Series D Preferred Stock [Member]
Statement [Line Items]
Preferred stock, shares par value | $ / shares		$ 0.01		$ 0.01
Preferred stock shares authorized		10,000		10,000
Series E Preferred Stock [Member]
Statement [Line Items]
Preferred stock, shares par value | $ / shares		$ 0.01		$ 0.01
Preferred stock shares authorized		250,000		250,000
Series F Preferred Stock [Member]
Statement [Line Items]
Preferred stock, shares par value | $ / shares		$ 0.01		$ 0.01
Preferred stock shares authorized		1,500,000		1,500,000

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Accrued Expenses Other
Convertible notes payable, bearing interest at 8- 10%	$ 1,911,098	$ 2,054,850
Unamortized debt discount	(43,562)	(68,219)
Unamortized deferred debt issuance cost	0	0
Total	1,867,536	1,986,631
Current portion	$ 1,867,536	$ 1,986,631

Convertible Notes Payable (De_2

Convertible Notes Payable (Details Narrative) - USD ($)					1 Months Ended					3 Months Ended		12 Months Ended
	Apr. 11, 2023	Dec. 12, 2022	Nov. 04, 2022	Sep. 07, 2022	Apr. 28, 2023	Apr. 27, 2023	Aug. 20, 2022	Jun. 15, 2022	Sep. 20, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2022
Statement [Line Items]
Financing cost										$ 38,050
Accrued interest												$ 3,029,162	$ 3,313,052
Proceeds from convertible note	$ 43,950				$ 100,000	$ 25,000
Amortization of discount										$ 24,657	$ 405,123
2021 Convertible Notes [Member]
Statement [Line Items]
Common stock shares issued, shares										2,299,000
Common stock shares issued, amount										$ 457,921
Loss on conversion										386,311
Fees										3,000
Convertible notes payable									$ 220,000			$ 1,412,000
Accrued interest										8,610
Common stock conversion note payable costs										60,000
Warrants expiry date									Sep. 20, 2022
Bear interest rate									8%			8%
Conversion price									$ 0.10			$ 0.10
2022 Convertible Notes
Statement [Line Items]
Financing cost										78,395
Convertible notes payable		$ 40,000	$ 25,000	$ 100,000			$ 49,850	$ 300,000		$ 800,000
Warrants expiry date		Jan. 05, 2024	May 04, 2023	Sep. 07, 2023			Feb. 20, 2023	Dec. 15, 2022
Bear interest rate		8%	10%	8%			8%	8%
Conversion price		$ 0.05	$ 0.30	$ 0.10			$ 0.30	$ 0.30		$ 0.10
Proceeds from convertible note								$ 300,000
Debt discount				$ 100,000				$ 200,000
Amortization of discount										$ 24,658
Convertible Notes
Statement [Line Items]
Common stock shares issued, shares										3,045,939
Common stock shares issued, amount										$ 546,932
Loss on conversion										460,930
Fees										2,250
Common stock conversion note payable costs										$ 83,752

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)		3 Months Ended
	Apr. 14, 2023	Mar. 31, 2023
Statement [Line Items]
Common stock value		$ 147,000
MonthlyPayment		$ 4,386
Common stock shares issued for service	570,000	1,500,000
Common stock shares issued remaining		500,000
June 12, 2020 [Member] | Small Business Administration Loan [Member]
Statement [Line Items]
Interest rate		3.75%
Loan amount		$ 150,000
Debt instrument, payment terms		Installment payments, including principal and interest, of $731 monthly, will begin 12 months from the date of the note
April 2021 [Member] | JMS Investments of Staten Island [Member]
Statement [Line Items]
Interest rate		8.50%
Total investments		$ 376,000
January 27, 2023 [Member] | Paycheck Protection Program [Member]
Statement [Line Items]
Loan and accrued interest forgiven		196,000
Loan amount		$ 350,000
Augustl 30, 2021 [Member] | Paycheck Protection Program [Member]
Statement [Line Items]
Common stock shares issued for service		120,990
Common stock shares issued remaining		1,000,000

Deferred Revenue (Details Narra

Deferred Revenue (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Deferred Revenue
Recognized license revenue	$ 12,500	$ 12,500
Royalty revenue	0	$ 0
Deferred Revenue	$ 236,156		$ 248,656

Commitments and Contingencies_2

Commitments and Contingencies (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)
Statement [Line Items]
Total	$ 112,459
Old Dominion Freight Line [Member]
Statement [Line Items]
Sum Owned	$ 13,575
Payment Plan	No
Legal Action	Yes
Power Plant Services [Member]
Statement [Line Items]
Sum Owned	$ 85,199
Payment Plan	No
Legal Action	Yes
SoftinWay[Member]
Statement [Line Items]
Sum Owned	$ 1,850
Payment Plan	Yes
Legal Action	Yes
The O-Ring Store [Member]
Statement [Line Items]
Sum Owned	$ 10,334
Payment Plan	No
Legal Action	Yes

Commitments and Contingencies_3

Commitments and Contingencies (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Statement [Line Items]
Account payable	$ 1,180,553	$ 1,401,934
...Verbal Repayment Agreement
Statement [Line Items]
Account payable	24,165
October 8, 2021 [Member] | Soex [Member]
Statement [Line Items]
Attorneys fees	300,568
Cost related to defendant	82,096
Settlement amount of creditor	28,781
Legal expenses	17,212
Unpaid debts to creditors fund	4,700
Total award to defendant	$ 382,664

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)				1 Months Ended				3 Months Ended
	Jun. 02, 2023	Apr. 14, 2023	Apr. 11, 2023	Jun. 28, 2023	Jun. 20, 2023	Apr. 28, 2023	Apr. 27, 2023	Mar. 31, 2023	Mar. 31, 2022
Subsequent Events
Proceed from convertible notes			$ 43,950			$ 100,000	$ 25,000
Shares issued for consulting services		570,000						1,500,000
Shares issued for notes payable conversions							887,595
Repayment to related party	$ 84,681							$ 350,000	$ 0
Proceed from notes payble	195,000
Repayment of notes payble	$ 11,259
Proceed from Senior secured note					$ 150,000
Repayment of secured notes				$ 12,000